These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19089921)

  • 1. Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.
    Tang Y; Wang MT; Chen Y; Yang D; Che M; Honn KV; Akers GD; Johnson SR; Nie D
    Int J Cancer; 2009 Apr; 124(7):1545-51. PubMed ID: 19089921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
    Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity.
    Hosseinymehr M; Matin MM; Sadeghian H; Bahrami AR; Kaseb-Mojaver N
    Anticancer Drugs; 2016 Oct; 27(9):854-62. PubMed ID: 27362790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
    Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
    Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Farnesyloxycoumarin Exerts Anti-cancer Effects on a Prostate Cancer Cell Line by 15-LOX-1 Inhibition.
    Saboormaleki S; Sadeghian H; Bahrami AR; Orafaie A; Matin MM
    Arch Iran Med; 2018 Jun; 21(6):251-259. PubMed ID: 29940744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.
    Sarveswaran S; Chakraborty D; Chitale D; Sears R; Ghosh J
    J Biol Chem; 2015 Feb; 290(8):4994-5006. PubMed ID: 25540201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon.
    Sarveswaran S; Thamilselvan V; Brodie C; Ghosh J
    Biochim Biophys Acta; 2011 Dec; 1813(12):2108-17. PubMed ID: 21824498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells.
    Nie D; Krishnamoorthy S; Jin R; Tang K; Chen Y; Qiao Y; Zacharek A; Guo Y; Milanini J; Pages G; Honn KV
    J Biol Chem; 2006 Jul; 281(27):18601-9. PubMed ID: 16638750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
    Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR
    Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase.
    Nie D; Nemeth J; Qiao Y; Zacharek A; Li L; Hanna K; Tang K; Hillman GG; Cher ML; Grignon DJ; Honn KV
    Clin Exp Metastasis; 2003; 20(7):657-63. PubMed ID: 14669797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
    Pidgeon GP; Kandouz M; Meram A; Honn KV
    Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells.
    Maleki F; Sadeghian H; Bahrami AR; Goftari SN; Matin MM
    Anticancer Agents Med Chem; 2023; 23(15):1722-1730. PubMed ID: 37171011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-Lipoxygenase-1 re-expression in colorectal cancer alters endothelial cell features through enhanced expression of TSP-1 and ICAM-1.
    Tunçer S; Keşküş AG; Çolakoğlu M; Çimen I; Yener C; Konu Ö; Banerjee S
    Cell Signal; 2017 Nov; 39():44-54. PubMed ID: 28757355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase.
    McCabe NP; Selman SH; Jankun J
    Prostate; 2006 May; 66(7):779-87. PubMed ID: 16482570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma.
    Hsi LC; Wilson LC; Eling TE
    J Biol Chem; 2002 Oct; 277(43):40549-56. PubMed ID: 12189136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.
    Shureiqi I; Wojno KJ; Poore JA; Reddy RG; Moussalli MJ; Spindler SA; Greenson JK; Normolle D; Hasan AA; Lawrence TS; Brenner DE
    Carcinogenesis; 1999 Oct; 20(10):1985-95. PubMed ID: 10506115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.